{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:33:20Z","timestamp":1786995200882,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016618","name":"Gilbert Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.omtn.2023.06.018","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T21:11:13Z","timestamp":1687813873000},"page":"227-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-5422","authenticated-orcid":false,"given":"Sara H.","family":"Osum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice I.","family":"Oribamise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas M.A.S.","family":"Corbi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Taisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Jubenville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Coutts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N.","family":"Kirstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Moertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bedwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Largaespada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9752-3689","authenticated-orcid":false,"given":"Adrienne L.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2023.06.018_bib1","first-page":"63","article-title":"NF1 Mutational Spectrum","volume":"16","author":"Messiaen","year":"2008"},{"key":"10.1016\/j.omtn.2023.06.018_bib2","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1007\/s00018-021-03809-7","article-title":"Nonsense suppression therapies in human genetic diseases","volume":"78","author":"Martins-Dias","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omtn.2023.06.018_bib3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/wrna.95","article-title":"Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases","volume":"2","author":"Keeling","year":"2011","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.omtn.2023.06.018_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.06.018_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.1023","article-title":"Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations","volume":"49","author":"Wagner","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2023.06.018_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","article-title":"Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy","volume":"67","author":"Malik","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2023.06.018_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI28523","article-title":"Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin","volume":"117","author":"Linde","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2023.06.018_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","article-title":"Ataluren for the treatment of nonsense-mutation cystic fibrosis: A randomised, double-blind, placebo-controlled phase 3 trial","volume":"2","author":"Kerem","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.omtn.2023.06.018_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s42003-018-0163-y","article-title":"Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1","volume":"1","author":"Isakson","year":"2018","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omtn.2023.06.018_bib10","first-page":"vdab020","article-title":"Selumetinib normalizes Ras\/MAPK signaling in clinically relevant neurofibromatosis type 1\u00a0minipig tissues in\u00a0vivo","volume":"3","author":"Osum","year":"2021","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.omtn.2023.06.018_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00210425","article-title":"Two further cases of mutation R1947X in the NF1 gene: screening for a relatively common recurrent mutation","volume":"96","author":"L\u00e1zaro","year":"1995","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtn.2023.06.018_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive Mutation Analysis of the NF1 Gene Allows Identification of 95% of Mutations and Reveals a High Frequency of Unusual Splicing Defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2023.06.018_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.0022-202X.2005.23834.x","article-title":"Gonosomal Mosaicism for a Nonsense Mutation (R1947X) in the NF1 Gene in Segmental Neurofibromatosis Type 1","volume":"125","author":"Consoli","year":"2005","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.omtn.2023.06.018_bib14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s100380050016","article-title":"A nonsense mutation at Arg-1947 in the NF1 gene in a case of neurofibromatosis type 1 in a Korean patient","volume":"45","author":"Park","year":"2000","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.omtn.2023.06.018_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1673-8527(08)60011-9","article-title":"The R1947X mutation of NF1 causing autosomal dominant neurofibromatosis type 1 in a Chinese family","volume":"35","author":"Yang","year":"2008","journal-title":"Journal of Genetics and Genomics"},{"key":"10.1016\/j.omtn.2023.06.018_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/ijms22010344","article-title":"Synergy between readthrough and nonsense mediated decay inhibition in a murine model of cystic fibrosis nonsense mutations","volume":"22","author":"McHugh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2023.06.018_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060478","article-title":"Attenuation of Nonsense-Mediated mRNA Decay Enhances In\u00a0Vivo Nonsense Suppression","volume":"8","author":"Keeling","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2023.06.018_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-0270(02)00349-7","article-title":"Magnetic cell sorting for enriching Schwann cells from adult mouse peripheral nerves","volume":"123","author":"Manent","year":"2003","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.omtn.2023.06.018_bib19","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1073\/pnas.0711795105","article-title":"PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model","volume":"105","author":"Du","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.06.018_bib20","doi-asserted-by":"crossref","first-page":"E6536","DOI":"10.1073\/pnas.1803154115","article-title":"Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa","volume":"115","author":"Lincoln","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.06.018_bib21","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm1197-1280","article-title":"Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line","volume":"3","author":"Bedwell","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2023.06.018_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"Barton-Davis","year":"1999","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2023.06.018_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00109-002-0363-1","article-title":"Aminoglycoside suppression of a premature stop mutation in a Cftr-\/- mouse carrying a human CFTR-G542X transgene","volume":"80","author":"Du","year":"2002","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.omtn.2023.06.018_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1741-7015-5-5","article-title":"In\u00a0vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: A pilot study","volume":"5","author":"Sermet-Gaudelus","year":"2007","journal-title":"BMC Med."},{"key":"10.1016\/j.omtn.2023.06.018_bib25","article-title":"Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms","volume":"118","author":"Nga","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.06.018_bib26","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1158\/0008-5472.CAN-13-2235","article-title":"Identification and characterization of small molecules that inhibit nonsense mediated RNA decay and suppress nonsense p53 mutations","volume":"74","author":"Martin","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2023.06.018_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/labinvest.2016.88","article-title":"Immortalization of human normal and NF1 neurofibroma Schwann cells","volume":"96","author":"Li","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.omtn.2023.06.018_bib28","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1038\/s41467-021-24575-x","article-title":"A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion","volume":"12","author":"Sharma","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2023.06.018_bib29","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1039\/C5OB02482J","article-title":"Synthesis and activity of a novel inhibitor of nonsense-mediated mRNA decay","volume":"14","author":"Gotham","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.omtn.2023.06.018_bib30","doi-asserted-by":"crossref","first-page":"22347","DOI":"10.1073\/pnas.1910292116","article-title":"Myelin sheath structure and regeneration in peripheral nerve injury repair","volume":"116","author":"Liu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.06.018_bib31","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1007\/s00018-016-2297-8","article-title":"Negative feedback regulation of the ERK1\/2 MAPK pathway","volume":"73","author":"Lake","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omtn.2023.06.018_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ng1987","article-title":"A module of negative feedback regulators defines growth factor signaling","volume":"39","author":"Amit","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2023.06.018_bib33","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1158\/1535-7163.MCT-16-0297","article-title":"Identification of pharmacodynamic transcript biomarkers in response to FGFR inhibition by AZD4547","volume":"15","author":"Delpuech","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omtn.2023.06.018_bib34","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1158\/1078-0432.CCR-16-0021","article-title":"Clinically viable gene expression assays with potential for predicting benefit from MEK inhibitors","volume":"23","author":"Brant","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2023.06.018_bib35","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1073\/pnas.0900780106","article-title":"V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway","volume":"106","author":"Pratilas","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.06.018_bib36","doi-asserted-by":"crossref","first-page":"giaa051","DOI":"10.1093\/gigascience\/giaa051","article-title":"An improved pig reference genome sequence to enable pig genetics and genomics research","volume":"9","author":"Warr","year":"2020","journal-title":"GigaScience"},{"key":"10.1016\/j.omtn.2023.06.018_bib37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.06.018_bib38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.06.018_bib39","series-title":"R: A Language and Environment for Statistical Computing","year":"2022"},{"key":"10.1016\/j.omtn.2023.06.018_bib40","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J.\u00a0Open Source Softw."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312300166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312300166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:41:17Z","timestamp":1761874877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312300166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":40,"alternative-id":["S216225312300166X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2023.06.018","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2023.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}]}}